Edwards EVOQUE Eos MISCEND Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 123 participants.
Also called NCT02718001
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 123 participants
- Sponsor
- Registry
-
NCT02718001
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Canada
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT02718001. Allocation not applicable; no masking; primary purpose treatment. Start 2015-02-06 (actual); primary completion 2028-04-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Edwards EVOQUE Eos MISCEND Study
- Condition
- Mitral Valve Regurgitation (Degenerative or Functional)
- Intervention (Device)
- Edwards EVOQUE Eos Mitral Valve Replacement System
- Lead sponsor
- Edwards Lifesciences
Record details
- Record id
cardio:ct-nct02718001- Content hash
cf915dd3006048866f74a23685fc4a15c2b0bf8c58dccdefc547bf8d825f76a9